| 摘要 |
Pharmacuetical composition comprising compounds of formula (I): <?in-line-formulae description="In-line Formulae" end="lead"?>NZ<SUB>1</SUB>Z<SUB>2</SUB>Z<SUB>3 </SUB> (I) <?in-line-formulae description="In-line Formulae" end="tail"?> in which: Z<SUB>1</SUB>, Z<SUB>2</SUB>, Z<SUB>3 </SUB>each independently of the others represents: a hydrogen atom; C<SUB>1</SUB>-C<SUB>6</SUB>-alkyl group; a group -SO<SUB>2</SUB>R<SUB>3 </SUB>wherein R<SUB>3 </SUB>represents a linear or branched C<SUB>1</SUB>-C<SUB>12</SUB>-alkyl, -alkenyl or -alkynyl group, a C<SUB>3</SUB>-C<SUB>10</SUB>-cycloalkyl group or a C<SUB>6</SUB>-C<SUB>10</SUB>-aryl group, a (C<SUB>1</SUB>-C<SUB>6</SUB>)-alkyl-(C<SUB>6</SUB>-C<SUB>14</SUB>)-aryl group, or a C<SUB>5</SUB>-C<SUB>10</SUB>-heteroaryl group; it being understood that at least one of the groups Z<SUB>1</SUB>, Z<SUB>2</SUB>, Z<SUB>3 </SUB>represents a group of formula (II) <?in-line-formulae description="In-line Formulae" end="lead"?>X-R<SUB>F</SUB>-(CH<SUB>2</SUB>)<SUB>n</SUB>-SO<SUB>2</SUB>- (II) <?in-line-formulae description="In-line Formulae" end="tail"?> X, RF and n being as defined in claim 1.
|
